Celldex (CLDX) outlook: barzolvolimab platform immunology beyond CSU, strong cash runway through 2027, Phase 3 data Q4’26, ...
Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); ...
Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); Topline data expected in Q4 26; BLA submission planned for ...
Good morning, and welcome to the IDEXX Laboratories First Quarter 2026 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...
Online influencers tout a mix of over-the-counter medications to address the symptoms of perimenopause and menopause. A ...
Spider veins can indicate that your circulatory system could use some support ...
Scientists have uncovered a surprising secret hidden inside fat cells that could reshape how we think about obesity and metabolic disease. A protein called HSL, long believed to simply release stored ...
A hallmark of type 2 diabetes is the progressive loss of beta cell mass: cells in the pancreas that produce and release ...
A next-gen Duchenne therapy from Entrada Therapeutics fell short in an early study, as a number of companies race to make ...
The molecule cAMP, which plays essential roles in mammalian cells, is less well understood in plants. In a new Science ...
A newly discovered type of liver cell may hold clues for treating severe liver disease, according to a recent study from the University of Michigan Life Sciences Institute. The findings, published in ...